The rapid emergence and re-emergence of viral pathogens—exemplified by outbreaks of influenza, Ebola, Zika, and, most recently, SARS-CoV-2—underscore the ...

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman ...

As the future of rare disease research at Cincinnati Children's is threatened, parents of 13-year-old Charlie Evans plead for its reinstatement.

HealthDay News — The National Institutes of Health (NIH) announced it will put a limit on publisher fees for publicly funded research by Fiscal Year 2026.

This scoping review aims to identify the methods used to economically evaluate clinical registries including their costs and benefits. Methods This systematic scoping review protocol has been ...